Lymph node harvest as a predictor of survival for colon cancer: A systematic review and meta-analysis
- Simarpreet Ichhpuniani 1, Tyler McKechnie 2, Jay Lee 1, Jeremy Biro 1, Yung Lee 2, Lily Park 2, Aristithes Doumouras 2,3, Dennis Hong 2,3, Cagla Eskicioglu 2,3
- 1Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
- 2Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
- 3Division of General Surgery, Department of Surgery, St. Joseph's Healthcare, Hamilton, Ontario, Canada.
- 0Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The number of lymph nodes examined impacts cancer survival predictions. While 12 lymph nodes are recommended, lower cut-offs like 7 may also predict survival outcomes, warranting further investigation.
Area Of Science
- Oncology
- Surgical Pathology
- Biostatistics
Background
- Lymph node harvest extent influences metastasis detection and oncologic outcome prediction.
- Current guidelines recommend a minimum of 12 lymph nodes for adequate lymphadenectomy.
- The predictive value of lymph node harvest cut-offs other than 12 remains underexplored.
Purpose Of The Study
- To review existing literature and determine optimal lymph node harvest cut-offs for predicting survival outcomes.
- To evaluate if lymph node harvest cut-offs below the recommended 12 can adequately predict long-term survival.
Main Methods
- Systematic literature search of Medline, Embase, and CENTRAL databases.
- Inclusion of studies comparing overall survival (OS) and disease-free survival (DFS) based on lymph node harvest cut-offs.
- Pairwise meta-analyses using inverse variance random effects for quantitative synthesis.
Main Results
- A lymph node harvest cut-off of 12 was associated with improved five-year OS.
- Cut-offs as low as 7 demonstrated improved five-year OS and DFS.
- All evaluated cut-offs exceeding 12 also showed improved survival outcomes.
Conclusions
- A lymph node cut-off of 12 is significant for predicting five-year oncologic outcomes.
- Lymph node harvests other than 12 lack rigorous study, limiting definitive conclusions.
- Further prospective research is needed to validate the adequacy of cut-offs below 12 for predicting long-term survival.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

